Newsletter Archive

  1. 01.20.20 -- Janssen Uses Geofencing To Monitor Clinical Trial Patients 1/20/2020
    01/20/20 Clinical Leader Newsletter
  2. 01.20.20 -- Don't Let Insufficient Data Undermine Your CMO & CRO Selection Processes 1/20/2020
    01/20/20 Clinical Leader Newsletter
  3. 01.20.20 -- Decision-making Responsibilities When Outsourcing Late-Phase Studies 1/20/2020
    01/20/20 Clinical Leader Newsletter
  4. 01.15.20 -- Master Trial Protocols: Better For Pharma, Better For Sites 1/15/2020
    01/15/20 Clinical Leader Newsletter
  5. 01.14.20 -- eCOA And eConsent: What You Need To Know 1/14/2020
    01/14/20 Clinical Leader Newsletter
  6. 01.13.20 -- BMS-Pfizer Alliance Evaluates AFib Screening And Stroke Connection 1/13/2020
    01/13/20 Clinical Leader Newsletter
  7. 01.09.20 -- Insights Into CRO Selection And Quality Benchmarking 1/9/2020
    01/09/20 Clinical Leader Newsletter
  8. 01.08.20 -- Acquiring And Implementing Innovation In The Pharmaceutical Industry 1/8/2020
    01/08/20 Clinical Leader Newsletter
  9. 01.07.20 -- Unlocking The Full Potential Of Precision Medicine In Oncology 1/7/2020
    01/07/20 Clinical Leader Newsletter
  10. 01.06.20 -- Study Reveals Nearly $215 Billion Economic Burden Of Nocturia 1/6/2020
    01/06/20 Clinical Leader Newsletter